GraniteShares Advisors’s Bio-Techne TECH Stock Holding History

GraniteShares Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,792	Closed	-$408K	–	101
2024 Q1	$408K	Sell	5,792 -205	-3%	-$14.7K	0.22%	92
2023 Q4	$463K	Sell	5,997 -110	-2%	-$7.25K	0.42%	88
2023 Q3	$416K	Buy	+6,107	New	+$482K	0.39%	86
2022 Q1	–	Sell	-768	Closed	-$99K	–	282
2021 Q4	$99K	Buy	+768	New	+$94.1K	0.05%	274

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

GraniteShares Advisors's TECH Position: Q2 2024 in Review

GraniteShares Advisors sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 5,792 shares — an estimated $408K sold.

GraniteShares Advisors first reported a position in TECH in Q4 2021 and held it in 4 quarters. The position peaked at $463K in Q4 2023. 572 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

GraniteShares Advisors reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
GraniteShares Advisors sold 5,792 Bio-Techne shares in Q2 2024, an estimated $408K.
GraniteShares Advisors first reported a position in Bio-Techne in Q4 2021 and held it in 4 quarters.
GraniteShares Advisors's Bio-Techne position peaked at $463K in Q4 2023.
572 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on GraniteShares Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.